Literature DB >> 22059646

Severe ranitidine-induced anaphylaxis: a case report and literature review.

K Aouam1, W Bouida, N Ben Fredj, A Chaabane, H Boubaker, R Boukef, N A Boughattas, S Nouira.   

Abstract

WHAT IS KNOWN AND
OBJECTIVE: Ranitidine is a generally well-tolerated drug, and serious side effects are rare. However, ranitidine-induced anaphylaxis has been reported on rare occasions. We report on such a case and review other cases reported in the literature. CASE
SUMMARY: A 36-year-old man with no history of other medications, illnesses or allergic diseases, especially to drugs, consulted our emergency department because of renal colic and epigastric discomfort. He was given 50 mg of ranitidine as a slow intravenous bolus and 20 mg of piroxicam intramuscularly. Within the first minute, the patient developed a cold sweat, trembling, dyspnoea and deterioration of his consciousness. The condition was considered as an anaphylactic shock, and cardiopulmonary resuscitation and inotropic support were immediately commenced. Two days later, he was weaned off the ventilator as he was haemodynamically stable. He was discharged after 7 days. Four weeks later, skin prick tests to ranitidine and piroxicam were performed on the forearm of the patient. He reacted strongly to ranitidine about 10 min later but not to piroxicam. To assess cross-reactivity to other H2- and H1-receptor antagonists in our patient, we subsequently performed prick tests to famotidine, cimetidine and desloratadine and all were negative. WHAT IS NEW AND
CONCLUSION: We re-emphasize a potentially serious, albeit very rare, adverse effect of ranitidine and summarize other reported cases. This case demonstrates that commonly used, generally safe drugs may on occasions cause serious adverse effects.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22059646     DOI: 10.1111/j.1365-2710.2011.01320.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  9 in total

1.  Ranitidine-Induced Anaphylaxis in a Patient with Acute COPD Exacerbation.

Authors:  İnsu Yılmaz; Murat Türk
Journal:  Turk Thorac J       Date:  2017-07-01

2.  Can H2 -receptor upregulation and raised histamine explain an anaphylactoid reaction on cessation of ranitidine in a 19-year-old female? A case report.

Authors:  Susan J Allen; Paul L Chazot; C Jane Dixon
Journal:  Br J Clin Pharmacol       Date:  2018-04-18       Impact factor: 4.335

3.  Anaphylaxis following intravenous ranitidine: a rare adverse reaction of a common drug.

Authors:  Deepti Chopra; Pooja Arora; Shamimullah Khan; Shridhar Dwivedi
Journal:  Indian J Pharmacol       Date:  2014 Mar-Apr       Impact factor: 1.200

4.  Guideline for acute therapy and management of anaphylaxis: S2 Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Association of German Allergologists (AeDA), the Society of Pediatric Allergy and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Society for Psychosomatic Medicine (DGPM), the German Working Group of Anaphylaxis Training and Education (AGATE) and the patient organization German Allergy and Asthma Association (DAAB).

Authors:  Johannes Ring; Kirsten Beyer; Tilo Biedermann; Andreas Bircher; Dorothea Duda; Jörg Fischer; Frank Friedrichs; Thomas Fuchs; Uwe Gieler; Thilo Jakob; Ludger Klimek; Lars Lange; Hans F Merk; Bodo Niggemann; Oliver Pfaar; Bernhard Przybilla; Franziska Ruëff; Ernst Rietschel; Sabine Schnadt; Roland Seifert; Helmut Sitter; Eva-Maria Varga; Margitta Worm; Knut Brockow
Journal:  Allergo J Int       Date:  2014

5.  The Basophil Activation Test Is Safe and Useful for Confirming Drug-Induced Anaphylaxis.

Authors:  Suk Yeon Kim; Joo Hee Kim; Young Sook Jang; Jeong Hee Choi; Sunghoon Park; Yong Il Hwang; Seung Hun Jang; Ki Suck Jung
Journal:  Allergy Asthma Immunol Res       Date:  2016-11       Impact factor: 5.764

6.  Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update: S2k-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Medical Association of German Allergologists (AeDA), the Society of Pediatric Allergology and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Society for Neonatology and Pediatric Intensive Care (GNPI), the German Society of Dermatology (DDG), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Respiratory Society (DGP), the patient organization German Allergy and Asthma Association (DAAB), the German Working Group of Anaphylaxis Training and Education (AGATE).

Authors:  Johannes Ring; Kirsten Beyer; Tilo Biedermann; Andreas Bircher; Matthias Fischer; Thomas Fuchs; Axel Heller; Florian Hoffmann; Isidor Huttegger; Thilo Jakob; Ludger Klimek; Matthias V Kopp; Claudia Kugler; Lars Lange; Oliver Pfaar; Ernst Rietschel; Franziska Rueff; Sabine Schnadt; Roland Seifert; Britta Stöcker; Regina Treudler; Christian Vogelberg; Thomas Werfel; Margitta Worm; Helmut Sitter; Knut Brockow
Journal:  Allergo J Int       Date:  2021-01-28

7.  The more allergens an atopic patient is exposed to, the easier and quicker anaphylactic shock and Kounis syndrome appear: Clinical and therapeutic paradoxes.

Authors:  N G Kounis; A Mazarakis; G Almpanis; K Gkouias; G N Kounis; G Tsigkas
Journal:  J Nat Sci Biol Med       Date:  2014-07

8.  Unusual and Interesting Adverse Cutaneous Drug Reactions.

Authors:  Vaishali Masatkar; Ashok Nagure; Lalit Kumar Gupta
Journal:  Indian J Dermatol       Date:  2018 Mar-Apr       Impact factor: 1.494

Review 9. 

Authors:  Johannes Ring; Kirsten Beyer; Tilo Biedermann; Andreas Bircher; Matthias Fischer; Axel Heller; Isidor Huttegger; Thilo Jakob; Ludger Klimek; Matthias V Kopp; Claudia Kugler; Lars Lange; Oliver Pfaar; Ernst Rietschel; Franziska Rueff; Sabine Schnadt; Roland Seifert; Britta Stöcker; Regina Treudler; Christian Vogelberg; Thomas Werfel; Margitta Worm; Helmut Sitter; Knut Brockow
Journal:  Allergo J       Date:  2021-02-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.